Globus Medical, Inc. (GMED) Q3 2016 Earnings Results

Globus Med Inc (GMED) Beats on EPS, Stock Down 1.02%

Globus Med's earnings report showed a slight beat on EPS, which indicates some positive momentum. However, the stock reacted negatively, declining by 1.02%. This could be due to the lack of revenue data and forward guidance, leaving investors uncertain about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.29	N/A	+2.84%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's future. They emphasized their commitment to innovation and navigating market challenges.

Management highlighted continued focus on innovation and product development.

They expressed confidence in long-term growth despite current market challenges.

Globus Med Inc (GMED) Beats on EPS, Stock Down 1.02%

Key numbers

Management commentary

Globus Medical, Inc.

More earnings this week

Globus Med Inc (GMED) Beats on EPS, Stock Down 1.02%

Key numbers

Management commentary